The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant treatments for resectable (RPC) and borderline resectable pancreatic adenocarcinoma (BRPC): A pairwise and network meta-analysis (NMA).
 
Elena Ongaro
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; MSD; SERVIER
 
Marco de Scordilli
No Relationships to Disclose
 
Fabiola Giudici
No Relationships to Disclose
 
Simone Rota
No Relationships to Disclose
 
Riccardo Vida
No Relationships to Disclose
 
Miriam Zilli
No Relationships to Disclose
 
Emma Zottarelli
No Relationships to Disclose
 
Paola Di Nardo
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Lilly; Roche
 
Luisa Foltran
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo
 
Arianna Fumagalli
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Michela Guardascione
Travel, Accommodations, Expenses - MSD
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Italfarmaco; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Viatris
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Amgen; Astrazeneca; Celgene; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pfizer; Roche